Cargando…

Dynamic Contrast-enhanced MRI in Renal Tumors: Common Subtype Differentiation using Pharmacokinetics

Preoperative renal tumor subtype differentiation is important for radiology and urology in clinical practice. Pharmacokinetic data (K (trans) & V (e), etc.) derived from dynamic contrast-enhanced MRI (DCE-MRI) have been used to investigate tumor vessel permeability. In this prospective study on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hai-yi, Su, Zi-hua, Xu, Xiao, Huang, Ning, Sun, Zhi-peng, Wang, Ying-wei, Li, Lu, Guo, Ai-tao, Chen, Xin, Ma, Xin, Ma, Lin, Ye, Hui-yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465189/ https://www.ncbi.nlm.nih.gov/pubmed/28596583 http://dx.doi.org/10.1038/s41598-017-03376-7

Ejemplares similares

Dynamic Contrast-enhanced MR Imaging in Renal Cell Carcinoma: Reproducibility of Histogram Analysis on Pharmacokinetic Parameters
por: Wang, Hai-yi, et al.
Publicado: (2016)

Reproducibility of Dynamic Contrast-Enhanced MRI in Renal Cell Carcinoma: A Prospective Analysis on Intra- and Interobserver and Scan–Rescan Performance of Pharmacokinetic Parameters
por: Wang, Haiyi, et al.
Publicado: (2015)

The diagnostic performance of dynamic contrast-enhanced MRI and its correlation with subtypes of breast cancer
por: Li, Xun, et al.
Publicado: (2021)

Pharmacokinetic analysis for the differentiation of pituitary microadenoma subtypes through dynamic contrast-enhanced magnetic resonance imaging
por: Zhai, Jian, et al.
Publicado: (2019)

Contrast‐Enhanced Ultrasound Features of Adult Xp11.2 Translocation Renal Cell Carcinoma: Differential Diagnosis With Three Main Renal Cell Carcinoma Subtypes
por: Ma, Wenliang, et al.
Publicado: (2022)

Different DNA Loidy Patterns for the Differentiation of Common Subtypes of Renal Tumors
por: Li, Guorong, et al.
Publicado: (2005)

The value of dynamic contrast–enhanced MRI in characterizing complex ovarian tumors
por: Li, Hai-Ming, et al.
Publicado: (2017)

Noninvasive Classification of Glioma Subtypes Using Multiparametric MRI to Improve Deep Learning
por: Xiong, Diaohan, et al.
Publicado: (2022)

A Suspicious Breast Lesion Detected by Dynamic Contrast-Enhanced MRI and Pathologically Confirmed as Capillary Hemangioma: a Case Report and Literature Review
por: Yang, Lian-He, et al.
Publicado: (2013)

Pharmacokinetic Changes Induced by Focused Ultrasound in Glioma-Bearing Rats as Measured by Dynamic Contrast-Enhanced MRI
por: Yang, Feng-Yi, et al.
Publicado: (2014)

Conventional, diffusion, and dynamic contrast-enhanced MRI findings for differentiating metaplastic Warthin’s tumor of the parotid gland
por: Jia, Chuan-Hai, et al.
Publicado: (2021)

Grading of pancreatic neuroendocrine neoplasms using pharmacokinetic parameters derived from dynamic contrast-enhanced MRI
por: Zhao, Weiwei, et al.
Publicado: (2018)

Pharmacokinetic parameters and radiomics model based on dynamic contrast enhanced MRI for the preoperative prediction of sentinel lymph node metastasis in breast cancer
por: Liu, Meijie, et al.
Publicado: (2020)

Discrepancy of contrast-enhanced ultrasonographic pattern with two contrast agents in steatohepatitic subtype hepatocellular carcinoma: A case report
por: Bo, Jiang, et al.
Publicado: (2022)

Diagnostic Significance of Diffusion-Weighted MRI in Renal Cancer
por: Lei, Yu, et al.
Publicado: (2015)

Contrast-enhanced ultrasound in detecting wall invasion and differentiating bland from tumor thrombus during robot-assisted inferior vena cava thrombectomy for renal cell carcinoma
por: Li, Qiu-Yang, et al.
Publicado: (2019)

Comparison of Diagnostic Efficacy Between Contrast-Enhanced Ultrasound and DCE-MRI for Mass- and Non-Mass-Like Enhancement Types in Breast Lesions
por: Liu, Wei, et al.
Publicado: (2020)

Use of specific contrast-enhanced CT regions of interest to differentiate renal oncocytomas from small clear cell and chromophobe renal cell carcinomas
por: Qu, Jian-Yi, et al.
Publicado: (2022)

Common Coherence Witnesses and Common Coherent States
por: Wang, Bang-Hai, et al.
Publicado: (2021)

Molecular subtyping and characterization of clear cell renal cell carcinoma by tumor differentiation trajectories
por: Pan, Xiu-wu, et al.
Publicado: (2023)

Dynamic contrast-enhanced MRI differentiates hepatocellular carcinoma from hepatic metastasis of rectal cancer by extracting pharmacokinetic parameters and radiomic features
por: Li, Jianzhi, et al.
Publicado: (2020)

Pharmacokinetics of Chiral Dendrimer-Triamine-Coordinated Gd-MRI Contrast Agents Evaluated by in Vivo MRI and Estimated by in Vitro QCM
por: Miyake, Yuka, et al.
Publicado: (2015)

Population Pharmacokinetic Study of Cefathiamidine in Infants With Augmented Renal Clearance
por: Du, Bin, et al.
Publicado: (2021)

Biocompatible Nanocomplexes for Molecular Targeted MRI Contrast Agent
por: Chen, Zhijin, et al.
Publicado: (2009)

Assessment of Fasudil on Contrast-Associated Acute Kidney Injury Using Multiparametric Renal MRI
por: Wang, Bin, et al.
Publicado: (2022)

The use of error-category mapping in pharmacokinetic model analysis of dynamic contrast-enhanced MRI data
por: Gill, Andrew B., et al.
Publicado: (2015)

Assessment of Semiquantitative Parameters of Dynamic Contrast-Enhanced Perfusion MR Imaging in Differentiation of Subtypes of Renal Cell Carcinoma
por: Abdel Razek, Ahmed Abdel Khalek, et al.
Publicado: (2016)

Assessment and characterisation of common renal masses with CT and MRI
por: Pallwein-Prettner, Leo, et al.
Publicado: (2011)

Size and PEG Length-Controlled PEGylated Monocrystalline Superparamagnetic Iron Oxide Nanocomposite for MRI Contrast Agent
por: Deng, Li-Hua, et al.
Publicado: (2021)

MRI-Based Grading of Clear Cell Renal Cell Carcinoma Using a Machine Learning Classifier
por: Chen, Xin-Yuan, et al.
Publicado: (2021)

Subtyping Cryptosporidium ryanae: A Common Pathogen in Bovine Animals
por: Yang, Xin, et al.
Publicado: (2020)

Evaluation of Physicochemical Properties, Pharmacokinetics, Biodistribution, Toxicity, and Contrast-Enhanced Cancer MRI of a Cancer-Targeting Contrast Agent, MT218
por: Li, Yajuan, et al.
Publicado: (2022)

The Value of Contrast-Enhanced Ultrasonography and Contrast-Enhanced CT in the Diagnosis of Malignant Renal Cystic Lesions: A Meta-Analysis
por: Lan, Dong, et al.
Publicado: (2016)

Radiomics Analysis Based on Contrast-Enhanced MRI for Prediction of Therapeutic Response to Transarterial Chemoembolization in Hepatocellular Carcinoma
por: Zhao, Ying, et al.
Publicado: (2021)

Arteriolosclerosis CSVD: a common cause of dementia and stroke and its association with cognitive function and total MRI burden
por: Hua, Min, et al.
Publicado: (2023)

Application of high-resolution ultrasound, real-time elastography, and contrast-enhanced ultrasound in differentiating solid thyroid nodules
por: Zhang, Yu-Zhi, et al.
Publicado: (2016)

Role of contrast-enhanced ultrasound in evaluating the efficiency of ultrasound guided percutaneous microwave ablation in patients with renal cell carcinoma
por: Li, Xin, et al.
Publicado: (2013)

The Principal of Dynamic Contrast Enhanced MRI, the Method of Pharmacokinetic Analysis, and Its Application in the Head and Neck Region
por: Chikui, Toru, et al.
Publicado: (2012)

DCE@urLAB: a dynamic contrast-enhanced MRI pharmacokinetic analysis tool for preclinical data
por: Ortuño, Juan E, et al.
Publicado: (2013)

Convolutional Neural Networks for Direct Inference of Pharmacokinetic Parameters: Application to Stroke Dynamic Contrast-Enhanced MRI
por: Ulas, Cagdas, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nqfvk8g0tuvcuhs8okces23l24